The serum-treated cells, but not cells held in serum-free conditions, became 2E12-positive (Fig. 1E), which pointed to the serum origin of the molecule recognized by the 2E12 antibody.
However, additional experiments are required to determine whether the S2 cells-derived Wg could associate with lipoprotein particles of Drosophila (rather than serum) origin, and whether in vivo effects of reggie-1 are lipoprotein-dependent or not.
While significant advances are made to culture conditions of permanent cell lines, current research is lacking that compares cultures of primary airway fibroblasts in different serum origins added to a standard culture medium or serum depleted medium, and how this may affect their differentiation.
According to previous studies, although there is accumulating evidence of miRNAs in the blood and serum, the origin of these circulating extracellular miRNAs remains unclear.
During most of the 20th century, biopharmacologic products, including vaccines, prophylactic serum, blood flasks, and animal-origin waste, were buried <1.5 m deep in the 12,000-m waste dump of a pharmaceutical research institute in Milan (Istituto Sieroterapico Milanese [ISM]).
Fetal bovine serum USA Origin was purchased from EuroClone (Paignton, UK).
Established NB human cell line SJ-N-KP [60] was cultured at 37°C, 5% CO2 in RPMI 1640 supplemented with 10% heat inactivated foetal bovine serum USA Origin, 100 µg/mL streptomycin and 100 U/mL penicillin.
D1 cells [29] were maintained in vitro in Iscove's modified Dulbecco's medium (IMDM, Euroclone) supplemented with 10% heat-inactivated fetal bovine serum (Gibco, origin: Australia), 100 IU/ml penicillin, 100 µg/ml streptomycin, 2 mM L-glutamine (all from Euroclone) and 50 µM β-mercaptoethanol (Sigma) plus 30% R1 medium (supernatant from NIH3T3 fibroblasts transfected with GM-CSF).
Cells were cultured in Dulbecco's modified Eagle's medium (DMEM; GIBCO, CA, USA), supplemented with 10%% fetal bovine serum (Standard South America origin, Lonza, MD, USA), 2 mmol/l L-glutamine (EuroClone, Milan, Italy), and 100 U Penicillin and 1,000 U Streptomycin (Biochrom AG, FL, USA).
Cells from WT (wild-type) and NFI-C knock-out embryos were cultured under the following conditions: 37°C, 5% CO2, DMEM (GIBCO, 41966), Supplementary 10% FBS (GIBCO, Fetal Bovine Serum, qualified origin US, 26140-079), 1% v/v nonessential amino-acids (GIBCO, 11140-035), 1% v/v L-glutamine (GIBCO, 25030-024).
Cells from wild-type (WT) and NFI-C knock-out (KO) embryos were cultured in DMEM medium under the following conditions: 37°C, 5% CO2, DMEM (GIBCO, 41966), Supplemental 10% FBS (GIBCO, Fetal Bovine Serum, qualified origin US, 26140 079), 1% v/v nonessential amino-acids (GIBCO, 11140 035), 1% v/v L-glutamine (GIBCO, 25030 024).
